The health-benefit claims for homeopathic medicines are “implausible” and the products should not be recognized officially as medicines nor eligible for coverage under public-health systems in the European Union, an EU science advisory group said.
The European Academies’ Science Advisory Council, drawn from the national science academies of EU members, also said the remedies should be held to the same standards for labeling and advertising as ordinary drugs.
Homeopathy is a theory devised by German physician Samuel Hahnemann (1755-1843), who believed that administering diluted doses of a substance whose effects mimic those of a disease would cure the disease. The substances are often diluted to below detectable levels in homeopathic therapies. There is no scientific evidence of the products’ medical benefit beyond a placebo effect, the EASAC said in a report.